Irinotecan

Title	Average Rating
Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.	90.00%
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced	90.00%
A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort	80.00%
The effect of whole-body hyperthermia combined with 'metronomic' chemotherapy on rat mammary adenocarcinoma metastases.	80.00%
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high...	80.00%
A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose-Escalation, Safety Study of the Chemot	70.00%
Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal......	60.00%
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symp	60.00%
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer.	50.00%
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib.	50.00%
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients.	50.00%

Languages